Caribou Biosciences Inc (United States) is listed on the Nasdaq and has a market capitalization of $165.64 million, with shareholders equity totaling $98.10 million.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Caribou Biosciences Inc reported $10.04 million in revenue, generating net income of $-103.41 million.
Key financial metrics include a P/E ratio of -1.60, a price-to-book (P/B) ratio of 1.69, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker CRBU.